As CGT Struggles To Scale, FDA’s New Designation Could Smooth Post-Approval Pivots

By /

Experts suggest the FDA’s Advanced Manufacturing Technologies designation could be a lifeline for improving production processes for approved cell and gene therapies.

Scroll to Top